Table 3 Comparison between those who had atherosclerotic vascular disease and those without atherosclerotic vascular disease among kidney disease patients

43.5 (36.0–50.0)

37.0 (30.0–44.0)

0.002*

27.0 (22.5–31.9)

26.4 (22.0–30.5)

0.394

0.92 (0.88–0.96)

0.89 (0.85–0.94)

0.028*

148.5 (131.0–164.0)

147.0 (127–167)

0.411

139.8 (116.3–161.0)

141.8 (130.3–155.3)

0.792

4.4 (3.4–5.3)

4.1 (3.5–4.7)

0.342

1.2 (0.8–1.6)

1.3 (0.7–1.8)

0.444

2.5 (1.7–3.3)

2.3 (1.8–2.7)

0.150

1.2 (1.0–1.4)

1.1 (0.9–1.4)

0.065

3.5 (2.8–4.4)

3.6 (3.1–4.6)

0.560

1.9 (1.5–2.9)

2.0 (1.6–2.6)

0.914

2.5 (1.8–3.4)

2.6 (2.1–3.6)

0.560

0.0 (−0.5–0.4)

0.1 (− 0.4–0.4)

0.202

3.2 (2.3–4.1)

3.0 (2.5–3.3)

0.518

9.5 (4.8–21.7)

10.1 (4.8–18.3)

0.868

58.5 (53.0–64.0)

61.0 (56.0–64.0)

0.257

3.9 (3.5–4.5)

3.8 (3.2–4.2)

0.050

122.9 (103.5–146.0)

98.6 (83.0–117.1)

< 0.001*

7.5 (3.0–11.0)

5 (0–9.0)

0.036

2.0 (1.0–5.0)

0.8 (0.5–1.0)

< 0.001*